Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Hypertension

Free Subscription 18.05.2020 1 BMJ 3 Circ Cardiovasc Imaging 1 Circ Cardiovasc Qual Outcomes 1 Clin Cardiol 1 Clin Exp Hypertens 3 Hypertension 1 J Am Coll Cardiol 1 J Cardiovasc Pharmacol 4 J Hum Hypertens 2 J Hypertens 2 PLoS One 1 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. MARKLUND M, Singh G, Greer R, Cudhea F, et al
   Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study.
   BMJ. 2020;369:m824.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

2. BURKETT DA, Patel SS, Mertens L, Friedberg MK, et al
   Relationship Between Left Ventricular Geometry and Invasive Hemodynamics in Pediatric Pulmonary Hypertension.
   Circ Cardiovasc Imaging. 2020;13:e009825.
   PubMed         Abstract available
   
   
3. KOESTENBERGER M, Hansmann G
   Left Ventricular Geometry and Near-Simultaneous Invasive Hemodynamics in Pediatric Pulmonary Hypertension.
   Circ Cardiovasc Imaging. 2020;13:e010787.
   PubMed        
   
   
4. DESAI A, Malaisrie SC, Cuttica M, Freed BH, et al
   Dual-Energy Computed Tomography as an Alternative Noninvasive Study for Evaluation of Chronic Thromboembolic Pulmonary Hypertension Postoperatively.
   Circ Cardiovasc Imaging. 2020;13:e010168.
   PubMed        
   
   

   
   Circ Cardiovasc Qual Outcomes

5. GILLMEYER KR, Rinne ST, Glickman ME, Lee KM, et al
   Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015.
   Circ Cardiovasc Qual Outcomes. 2020 May 12:CIRCOUTCOMES119005993.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

6. LI W, Zhao J, Song L, Chen S, et al
   Combined effects of carotid plaques and hypertension on the risk of cardiovascular disease and all-cause mortality.
   Clin Cardiol. 2020 May 12. doi: 10.1002/clc.23372.
   PubMed         Abstract available
   
   

   
   Clin Exp Hypertens

7. ZHOU X, Zhu J, Xu T
   Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.
   Clin Exp Hypertens. 2020 May 13:1-5. doi: 10.1080/10641963.2020.1764018.
   PubMed         Abstract available
   
   

   
   Hypertension

8. ZHANG W, Wang JG
   Prevention of Atrial Fibrillation by Intensive Antihypertensive Treatment.
   Hypertension. 2020;75:1414-1416.
   PubMed        
   
   
9. 
   Hypertension Editors' Picks: Novel Drugs.
   Hypertension. 2020;75:e17-e28.
   PubMed        
   
   
10. LI Q, Xu S, Chen X, Zhang X, et al
    Folic Acid Supplement Use and Increased Risk of Gestational Hypertension.
    Hypertension. 2020 May 11:HYPERTENSIONAHA11914621.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

11. HASAN B, Hansmann G, Budts W, Heath A, et al
    Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:2463-2477.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

12. HOPPER RK, Ivy DD, Yung D, Mullen MP, et al
    Pharmacokinetics of Oral Treprostinil in Children with Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Apr 16. doi: 10.1097/FJC.0000000000000842.
    PubMed         Abstract available
    
    

    
    J Hum Hypertens

13. NADAR SK, Tayebjee MH, Stowasser M, Byrd JB, et al
    Managing hypertension during the COVID-19 pandemic.
    J Hum Hypertens. 2020 May 14. pii: 10.1038/s41371-020-0356.
    PubMed        
    
    
14. WEINBERG RL, Rubenfire M, Brook RD
    Coronary artery calcium scoring in patients with hypertension.
    J Hum Hypertens. 2020 May 12. pii: 10.1038/s41371-020-0350.
    PubMed         Abstract available
    
    
15. ANGELI F, Reboldi G, Verdecchia P
    Management of hypertension in the very old: an intensive reduction of blood pressure should be achieved in most patients.
    J Hum Hypertens. 2020 May 12. pii: 10.1038/s41371-020-0345.
    PubMed         Abstract available
    
    
16. KIBRIA GMA
    "Prevalence and Trends of Isolated Systolic Hypertension among Untreated Older People in the US according to the 2017 ACC/AHA Guideline, 2001-16".
    J Hum Hypertens. 2020 May 12. pii: 10.1038/s41371-020-0351.
    PubMed        
    
    

    
    J Hypertens

17. YU ES, Hong K, Chun BC
    Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study.
    J Hypertens. 2020 May 13. doi: 10.1097/HJH.0000000000002494.
    PubMed         Abstract available
    
    
18. LENDERS JWM, Kerstens MN, Amar L, Prejbisz A, et al
    Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension.
    J Hypertens. 2020 May 13. doi: 10.1097/HJH.0000000000002438.
    PubMed         Abstract available
    
    

    
    PLoS One

19. ZHANG L, Yuan M, An Z, Zhao X, et al
    Prediction of hypertension, hyperglycemia and dyslipidemia from retinal fundus photographs via deep learning: A cross-sectional study of chronic diseases in central China.
    PLoS One. 2020;15:e0233166.
    PubMed         Abstract available
    
    
20. KAISER R, Liu D, Arias-Loza P, Hu K, et al
    Right ventricular pressure overload directly affects left ventricular torsion mechanics in patients with precapillary pulmonary hypertension.
    PLoS One. 2020;15:e0232544.
    PubMed         Abstract available
    
    

    
    Stroke

21. LIANG YQ, Kakino A, Matsuzaka Y, Mashimo T, et al
    LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1) Deletion Has Protective Effects on Stroke in the Genetic Background of Stroke-Prone Spontaneously Hypertensive Rat.
    Stroke. 2020 May 1:STROKEAHA120029421. doi: 10.1161/STROKEAHA.120.029421.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: